Corvus (CRVS) news
Recent news
Corus Entertainment raises revolver to C$155M from C$125M
Corus Entertainment Inc. (TSX: CJR.B) has increased its senior secured revolving credit facility from C$125 million to C$155 million as part of its ongoing recapitalization efforts. This adjustment is outlined in the company’s previously announced recapitalization transaction, which aims to reduce…
AInvest Wire · Oct 1, 2026Corvus Pharmaceuticals announces initiation of phase 1B clinical trial of Soquelitinib for patients with hidradenitis suppurativa
Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS) has initiated a Phase 1b clinical trial of soquelitinib for patients with hidradenitis suppurativa (HS), a chronic inflammatory skin condition characterized by painful abscesses and nodules. The trial is part of the company’s broader strategy to explore…
AInvest Wire · Sep 30, 2026L3Harris delivering counter-drone systems to US Army
L3Harris Technologies (NYSE: LHX) has significantly expanded its production of VAMPIRE counter-unmanned systems (C-UxS) to meet growing demand from the U.S. Army and its allies. The company recently initiated high-volume manufacturing of the VAMPIRE system at its facility in Huntsville, Alabama, to…
AInvest Wire · Jun 10, 2026Corvus Pharmaceuticals - participates in $13.5 mln financing for Angel Pharmaceuticals
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) has been actively involved in the development and strategic expansion of its pipeline through its partnership with Angel Pharmaceuticals, a China-based biopharmaceutical company. In October 2020, Corvus co-founded Angel Pharmaceuticals and secured a 49.7%…
AInvest Wire · Jun 9, 2026Corvus Pharma announces additional investment in Angel Pharma
AInvest Wire · Jun 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.